Bionano Genomics, Inc. (BNGO)
The price, the headline numbers and the latest news, in one place.
Bionano Genomics, Inc. (BNGO) Stock Price, Analysis & Data
| Bid | 0.85 |
| Market Cap | 13.9M |
| Revenue (ttm) | 30.2M |
| Net Income (ttm) | -32.2M |
| 1.65 | |
| -3.01 | |
| n/a | |
| -1.22 | |
| P/B (ttm) | 0.44 |
| P/S (ttm) | 0.46 |
| Earnings Date | Nov 12, 2026 |
| Ask | 1.53 |
| Volume | 69,338 |
| Avg. Volume (20D) | 135,022 |
| Open | 1.19 |
| Previous Close | 1.20 |
| Day's Range | 1.18 - 1.22 |
| 52-Week Range | 1.00 - 5.50 |
| Analyst | n/a |
| Price Target | 5 (323.73%) |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About BNGO
Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, China, Japan, South Korea, Singapore, India, and Australia. The company offers genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It also provides Sa...
Financial Performance
In 2025, Bionano Genomics's revenue was 28.51M, a decrease of -7.37% compared to the previous year's 30.78M. Earnings were -26.4M, a decrease of -76.44%.
Financial StatementsAnalyst Forecast
According to 2 analyst ratings, the average rating for BNGO stock is "null". The 12-month stock price forecast is 5, which is upside of 323.73% from the latest price.
Stock ForecastsEarnings Surprise
- Revenue of $8.17M misses estimates by $0, with 21.36% YoY growth.
- EPS of -0.6 exceeds estimates by 0.07, with 69.54% YoY growth.
Analysts project revenue of ... Upgrade
